Results 181 to 190 of about 266,977 (390)

Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats. [PDF]

Int J Mol Sci, 2023
Tornling G, Batta R, Salvail D, Raud J, Denton CP.   +4 more
europepmc   +1 more source

Corrigendum to “Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2” [PDF]

, 2019
Yong Wang, Chun Li, Yulin Ouyang, Junda Yu, Shuzhen Guo, Zhongyang Liu, Dong Li, Jing Han, Wei Wang   +8 more
openalex   +1 more source

Angiotensin II type 2 receptor mediates programmed cell death.

Proceedings of the National Academy of Sciences of the United States of America, 1996
T. Yamada, M. Horiuchi, V. Dzau
semanticscholar   +1 more source

Association of Pregabalin vs. Duloxetine with Cardiovascular Events: A Retrospective Cohort Study Among US Veterans With Chronic Musculoskeletal Pain

Clinical Pharmacology &Therapeutics, EarlyView.
Pregabalin and duloxetine are widely prescribed non‐opioid medications for chronic musculoskeletal pain. Pregabalin may increase the risk of heart failure, and duloxetine increases heart rate and blood pressure; however, little is known about their comparative cardiovascular safety.
Sachalee Campbell, Puran Nepal, Laura Daniel, Otis Wilson, Alyson L. Dickson, Jennifer Maizel, Katherine T. Murray, William D. Dupont, Adriana Hung, Wayne A. Ray, C. Michael Stein, Cecilia P. Chung   +11 more
wiley   +1 more source

Angiotensin II type 2 receptor activation preserves megalin in the kidney and prevents proteinuria in high salt diet fed rats. [PDF]

Sci Rep, 2023
Kulkarni K, Patel S, Ali R, Hussain T.
europepmc   +1 more source

Increased Expression of Angiotensin Converting Enzyme 2 in Conjunction with Reduction of Neointima by Angiotensin II Type 1 Receptor Blockade [PDF]

, 2008
Michiya Igase, Katsuhiko Kohara, Tokihisa Nagai, Tetsuro Miki, Carlos M. Ferrario   +4 more
openalex   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

Inhibition of the angiotensin II type 2 receptor AT₂R is a novel therapeutic strategy for glioblastoma. [PDF]

Proc Natl Acad Sci U S A, 2022
Perryman R, Renziehausen A, Shaye H, Kostagianni AD, Tsiailanis AD, Thorne T, Chatziathanasiadou MV, Sivolapenko GB, El Mubarak MA, Han GW, Zarzycka B, Katritch V, Lebon G, Lo Nigro C, Lattanzio L, Morse SV, Morse SV, Choi JJ, O'Neill K, Kanaki Z, Klinakis A, Crook T, Cherezov V, Tzakos AG, Syed N.   +24 more
europepmc   +1 more source

Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure [PDF]

, 2000
Toshiyuki Matsumoto
openalex   +1 more source

Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism

Science, 2011
J. Habashi, J. Doyle, Tammy M. Holm, Hamza Aziz, F. Schoenhoff, D. Bedja, Yichun Chen, Alexandra N. Modiri, D. Judge, H. Dietz   +9 more
semanticscholar   +1 more source